See more : PharmaCielo Ltd. (PCLO.V) Income Statement Analysis – Financial Results
Complete financial analysis of Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tibet Cheezheng Tibetan Medicine Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Clairvest Group Inc. (CVTGF) Income Statement Analysis – Financial Results
- Fuji Seiki Co.,Ltd. (6400.T) Income Statement Analysis – Financial Results
- MW Investment Holding Group, Inc. (MEGH) Income Statement Analysis – Financial Results
- Dingdang Health Technology Group Ltd. (9886.HK) Income Statement Analysis – Financial Results
- First National of Nebraska, Inc. (FINN) Income Statement Analysis – Financial Results
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
About Tibet Cheezheng Tibetan Medicine Co., Ltd.
Tibet Cheezheng Tibetan Medicine Co., Ltd. together with its subsidiaries, engages in the research, development, production, and sale of Tibetan medicine in China. It provides drug products in the areas of cardiovascular, respiratory, digestive, urinary and reproductive system, nervous system, musculoskeletal system, and gynecological disorders. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.01B | 2.04B | 1.77B | 1.48B | 1.40B | 1.21B | 1.05B | 968.35M | 994.73M | 950.11M | 969.47M | 934.27M | 789.23M | 523.65M | 469.30M | 413.48M | 339.27M | 267.92M |
| Cost of Revenue | 323.31M | 324.14M | 265.34M | 206.73M | 180.30M | 147.96M | 133.12M | 150.03M | 201.05M | 250.05M | 356.38M | 436.59M | 359.25M | 135.93M | 97.25M | 70.63M | 63.28M | 56.75M |
| Gross Profit | 1.69B | 1.72B | 1.51B | 1.27B | 1.22B | 1.07B | 920.03M | 818.32M | 793.68M | 700.05M | 613.09M | 497.69M | 429.97M | 387.72M | 372.05M | 342.85M | 275.99M | 211.17M |
| Gross Profit Ratio | 83.92% | 84.15% | 85.01% | 86.00% | 87.15% | 87.80% | 87.36% | 84.51% | 79.79% | 73.68% | 63.24% | 53.27% | 54.48% | 74.04% | 79.28% | 82.92% | 81.35% | 78.82% |
| Research & Development | 50.54M | 55.09M | 70.82M | 60.32M | 55.55M | 36.81M | 25.76M | 28.89M | 30.55M | 31.26M | 25.45M | 17.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 55.29M | 47.67M | 43.24M | 33.84M | 55.19M | 21.24M | 18.00M | 22.98M | 26.99M | 23.49M | 29.68M | 24.06M | 52.76M | 49.91M | 39.02M | 33.95M | 30.65M | 16.99M |
| Selling & Marketing | 672.13M | 938.17M | 842.71M | 714.90M | 699.72M | 629.99M | 517.51M | 462.97M | 410.08M | 353.44M | 281.70M | 217.78M | 183.95M | 186.48M | 184.81M | 177.86M | 151.07M | 100.51M |
| SG&A | 1.11B | 985.84M | 885.94M | 748.75M | 754.90M | 651.22M | 535.51M | 485.95M | 437.07M | 376.93M | 311.38M | 241.84M | 236.71M | 236.39M | 223.83M | 211.81M | 181.72M | 117.50M |
| Other Expenses | 844.24K | 77.98M | 50.52M | 37.53M | 43.49M | -3.71M | 2.37M | 38.47M | 18.31M | 53.29M | 38.43M | 15.85M | 7.68M | 19.88M | 13.35M | 3.75M | 8.75M | 7.20M |
| Operating Expenses | 1.16B | 1.12B | 1.01B | 846.60M | 853.95M | 744.52M | 605.59M | 566.60M | 542.71M | 465.20M | 388.88M | 298.45M | 245.75M | 243.48M | 231.77M | 218.19M | 187.37M | 121.87M |
| Cost & Expenses | 1.54B | 1.44B | 1.27B | 1.05B | 1.03B | 892.48M | 738.71M | 716.63M | 743.76M | 715.25M | 745.26M | 735.04M | 605.01M | 379.41M | 329.02M | 288.82M | 250.65M | 178.62M |
| Interest Income | 13.14M | 16.96M | 34.44M | 42.66M | 16.57M | 32.96M | 3.38M | 2.88M | 4.39M | 3.96M | 11.36M | 10.82M | 11.70M | 10.79M | 9.96M | 8.29M | 4.23M | 0.00 |
| Interest Expense | 63.07M | 56.42M | 53.43M | 19.53M | 1.80M | 0.00 | 3.90M | 3.08M | 560.08K | 3.78M | 180.10K | 129.29K | 144.39K | 81.10K | 0.00 | 214.20K | 336.60K | 0.00 |
| Depreciation & Amortization | 95.77M | 85.91M | 66.54M | 43.84M | 36.09M | 24.58M | 22.68M | 30.55M | 33.24M | 25.40M | 24.02M | 15.60M | 12.18M | 8.84M | 9.81M | 9.86M | 9.97M | 5.42M |
| EBITDA | 805.09M | 721.11M | 617.22M | 509.72M | 442.32M | 380.98M | 348.94M | 347.55M | 325.48M | 260.26M | 248.22M | 214.83M | 196.40M | 182.77M | 150.08M | 146.31M | 127.86M | 95.59M |
| EBITDA Ratio | 40.05% | 32.54% | 50.90% | 34.57% | 31.04% | 31.36% | 34.03% | 36.15% | 33.24% | 28.23% | 27.24% | 23.31% | 24.89% | 35.03% | 32.18% | 35.39% | 37.86% | 35.68% |
| Operating Income | 466.28M | 521.54M | 790.21M | 457.28M | 401.53M | 354.05M | 321.66M | 275.32M | 273.09M | 232.91M | 219.71M | 207.01M | 195.30M | 154.10M | 149.79M | 133.44M | 109.08M | 97.28M |
| Operating Income Ratio | 23.19% | 25.51% | 44.63% | 30.98% | 28.63% | 29.18% | 30.54% | 28.43% | 27.45% | 24.51% | 22.66% | 22.16% | 24.75% | 29.43% | 31.92% | 32.27% | 32.15% | 36.31% |
| Total Other Income/Expenses | 178.13M | -2.34M | -2.29M | -10.64M | -269.93K | 29.07M | 241.63K | 38.33M | 18.29M | 53.15M | 38.19M | 15.84M | 7.64M | 30.36M | 22.84M | 3.70M | 8.47M | 7.14M |
| Income Before Tax | 644.41M | 519.20M | 787.91M | 446.70M | 401.26M | 350.33M | 324.03M | 313.76M | 291.37M | 286.06M | 257.90M | 222.85M | 202.94M | 173.93M | 162.67M | 137.14M | 117.55M | 104.42M |
| Income Before Tax Ratio | 32.06% | 25.39% | 44.50% | 30.26% | 28.61% | 28.88% | 30.77% | 32.40% | 29.29% | 30.11% | 26.60% | 23.85% | 25.71% | 33.21% | 34.66% | 33.17% | 34.65% | 38.98% |
| Income Tax Expense | 65.24M | 49.69M | 77.09M | 40.78M | 36.87M | 32.89M | 23.26M | 25.98M | 30.01M | 50.59M | 46.73M | 35.05M | 32.29M | 3.34M | 1.48M | 1.19M | 1.62M | 70.61K |
| Net Income | 581.20M | 472.54M | 715.88M | 403.96M | 364.25M | 318.77M | 300.84M | 289.86M | 264.91M | 237.53M | 213.37M | 190.18M | 170.72M | 170.46M | 160.81M | 135.80M | 115.84M | 105.95M |
| Net Income Ratio | 28.91% | 23.11% | 40.43% | 27.36% | 25.97% | 26.27% | 28.57% | 29.93% | 26.63% | 25.00% | 22.01% | 20.36% | 21.63% | 32.55% | 34.27% | 32.84% | 34.14% | 39.55% |
| EPS | 1.10 | 0.89 | 1.35 | 0.76 | 0.69 | 0.60 | 0.57 | 0.55 | 0.50 | 0.45 | 0.41 | 0.36 | 0.32 | 0.32 | 0.32 | 0.28 | 0.25 | 2.04 |
| EPS Diluted | 1.10 | 0.89 | 1.35 | 0.76 | 0.69 | 0.60 | 0.57 | 0.55 | 0.50 | 0.45 | 0.41 | 0.36 | 0.32 | 0.32 | 0.32 | 0.28 | 0.25 | 2.04 |
| Weighted Avg Shares Out | 529.71M | 530.22M | 528.63M | 528.61M | 527.74M | 527.15M | 527.12M | 527.12M | 527.08M | 522.71M | 522.70M | 525.35M | 527.74M | 526.94M | 497.11M | 476.51M | 470.00M | 51.91M |
| Weighted Avg Shares Out (Dil) | 530.10M | 530.22M | 529.22M | 528.61M | 527.74M | 527.15M | 527.12M | 527.16M | 527.12M | 522.71M | 522.70M | 525.35M | 527.74M | 526.94M | 497.11M | 476.51M | 470.00M | 51.91M |
No news found for: 002287.SZ
Source: https://incomestatements.info
Category: Stock Reports